Brain inflammation is induced by co-morbidities and risk factors for stroke.
about
Targeting innate immunity for neurodegenerative disorders of the central nervous systemNew insights into coupling and uncoupling of cerebral blood flow and metabolism in the brainStaging Models in Bipolar Disorder: A Systematic Review of the LiteratureAneurysmal Subarachnoid Hemorrhage and Neuroinflammation: A Comprehensive ReviewNeuroinflammatory basis of metabolic syndromeFenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent modelsMechanisms of Comorbidities Associated With the Metabolic Syndrome: Insights from the JCR:LA-cp Corpulent Rat StrainAgricultural exposures and stroke mortality in the Agricultural Health StudyImmunological profile of silent brain infarction and lacunar strokeMaintaining brain health by monitoring inflammatory processes: a mechanism to promote successful agingBrain immune interactions and air pollution: macrophage inhibitory factor (MIF), prion cellular protein (PrP(C)), Interleukin-6 (IL-6), interleukin 1 receptor antagonist (IL-1Ra), and interleukin-2 (IL-2) in cerebrospinal fluid and MIF in serum diffMouse models to study the effect of cardiovascular risk factors on brain structure and cognitionDiagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder.High-fat diet-induced memory impairment in triple-transgenic Alzheimer's disease (3xTgAD) mice is independent of changes in amyloid and tau pathology.Regional astrogliosis in the mouse hypothalamus in response to obesity.Rheumatoid arthritis and the risk of bipolar disorder: a nationwide population-based study.Lectin-like ox-LDL receptor-1 (LOX-1)-Toll-like receptor 4 (TLR4) interaction and autophagy in CATH.a differentiated cells exposed to angiotensin II.Obesity and cognitive decline: role of inflammation and vascular changes.Irritable brain caused by irritable bowel? A nationwide analysis for irritable bowel syndrome and risk of bipolar disorder.Systemic inflammation impairs tissue reperfusion through endothelin-dependent mechanisms in cerebral ischemia.Adhesion molecules, altered vasoreactivity, and brain atrophy in type 2 diabetes.Etanercept in Alzheimer disease: A randomized, placebo-controlled, double-blind, phase 2 trialDifferential expression of hypothalamic, metabolic and inflammatory genes in response to short-term calorie restriction in juvenile obese- and lean-prone JCR rats.Prolonged diet induced obesity has minimal effects towards brain pathology in mouse model of cerebral amyloid angiopathy: implications for studying obesity-brain interactions in mice.Lack of neuroinflammation in the HIV-1 transgenic rat: an [(18)F]-DPA714 PET imaging studyNoninvasive molecular imaging of neuroinflammationSystems analysis of eleven rodent disease models reveals an inflammatome signature and key drivers.Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats.Cognition and Hemodynamics.Can bipolar disorder be viewed as a multi-system inflammatory disease?Viscoelastic and ultrastructural characteristics of whole blood and plasma in Alzheimer-type dementia, and the possible role of bacterial lipopolysaccharides (LPS)Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitariusEffects of minocycline plus tissue plasminogen activator combination therapy after focal embolic stroke in type 1 diabetic rats.Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type miceCardio-metabolic risk factors and cortical thickness in a neurologically healthy male population: Results from the psychological, social and biological determinants of ill health (pSoBid) study.The neuropathology of obesity: insights from human disease.Cerebral ischemic damage in diabetes: an inflammatory perspective.Obesity and neuroinflammatory phenotype in mice lacking endothelial megalin.Lifetime Modulation of the Pain System via Neuroimmune and Neuroendocrine Interactions.Interleukin-1 and stroke: biomarker, harbinger of damage, and therapeutic target.
P2860
Q26744219-A926626D-34A3-4709-A741-6D766432ACC1Q26745457-36878D3D-F365-49F2-94ED-2F205E3E05EEQ26749336-02B3FEF8-471F-499D-93AF-6A83EC579C1FQ26751399-139E473B-8FE8-4D32-84F9-1E5B46F9E671Q26852584-64F95541-FDC6-4C64-BA50-F77F42EF12CAQ27332452-A5CFAE9F-9B6E-43F2-933D-543768487244Q28066227-3C647149-F31C-4A95-85E3-89202E87E6BCQ28388625-73390E12-2EB9-45F3-AD54-5774DB0B42BBQ28534571-CD1E8122-3B7B-442D-8AF3-67C1FD1CA1BAQ28730725-3C745B87-B91D-461F-BE70-122F1B8BA3E1Q30416813-B2DDB525-E934-4ED5-BD8A-1E480ECE6489Q30427103-E538F432-C17E-4F61-80D7-38575E1B314EQ33601890-CF4DEA48-91BA-4E6D-AF5E-58CCEF889190Q33624475-139131DE-D308-4510-88AB-1FF68DFFC02BQ33723977-4A7B9B38-9349-40BD-80C5-E8A6BD321BDCQ34206659-C6FD0C01-DC65-4BCA-851B-8283B82EA944Q34423160-513955F2-FE05-4931-9943-906790865705Q34540572-26B97A71-2C94-4A90-8EAC-4C1E21A00689Q35175847-E020BCD9-6DF6-4C6B-BFBB-C9E10851C89AQ35187936-64FF44E6-385A-471F-810E-5AADC2B65293Q35408197-CAA2926B-BC7C-400D-981F-72711DBF5269Q35671005-86FFE99A-6898-4DDE-9076-7A19A356F32CQ36022455-F2E2AD89-808C-44A6-A9A2-42CEEF96F225Q36051462-28F0DFFF-0DD3-436A-B1FF-A6C9D42189A6Q36070781-82433CC1-8063-41F4-B235-789617AFEA5BQ36079268-0D40FB4E-5701-4A0D-91F1-DE8709621158Q36171138-B7ADC836-CE54-4E9D-907C-BE2E1337F1F4Q36211358-6E1F8DE0-37A5-454C-9B5C-7B7388BFDC8BQ36292056-12CB2432-7205-439D-B9C2-632136195D90Q36401142-6E8D74E0-48F7-4730-BFA3-5A5FC836FB0EQ36546334-90C521DE-E5DC-4A7F-A98B-62B2663FAD3CQ36635045-568B1E33-5067-45DA-B42F-526C4616944CQ36783536-721EC63E-9BF9-46BB-8A27-2FA69F79BD58Q36958137-24E2621C-947F-4397-BE2B-D78658E45033Q37184586-10A345B5-F2F8-411B-8C0A-4AA841E91A0FQ37432600-C8DCB381-7FAA-4DA1-8281-7B758A1E20DBQ37602716-5D761176-2D75-4FCC-B355-49BA4F8EDF4FQ37615654-2984099F-41B5-490F-9B57-3CB3E9C00C6AQ37695333-8ECCC234-ADEB-4B7F-84DE-D4703EDB5F66Q37959134-4DC2A583-514D-4930-B80D-08DA6AD82FD9
P2860
Brain inflammation is induced by co-morbidities and risk factors for stroke.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Brain inflammation is induced by co-morbidities and risk factors for stroke.
@ast
Brain inflammation is induced by co-morbidities and risk factors for stroke.
@en
type
label
Brain inflammation is induced by co-morbidities and risk factors for stroke.
@ast
Brain inflammation is induced by co-morbidities and risk factors for stroke.
@en
prefLabel
Brain inflammation is induced by co-morbidities and risk factors for stroke.
@ast
Brain inflammation is induced by co-morbidities and risk factors for stroke.
@en
P2093
P2860
P50
P1476
Brain inflammation is induced by co-morbidities and risk factors for stroke.
@en
P2093
Adam Denes
Alison Smigova
Caroline Drake
Christian Prenant
David Crossman
Gavin Brown
James C Russell
Johann R Selvarajah
Karl Herholz
P2860
P304
P356
10.1016/J.BBI.2011.02.008
P50
P577
2011-02-26T00:00:00Z